Francisco M. Mouro

<p>In vivo Bio-Distribution and Toxicity Evaluation of Polymeric and Lipid-Based Nanoparticles: A Potential Approach for Chronic Diseases Treatment</p>

João Fonseca‐Gomes, Joana A. Loureiro, Sara R. Tanqueiro et al. · International Journal of Nanomedicine · 2020 · 59 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Chronic and acute adenosine A2A receptor blockade prevents long-term episodic memory disruption caused by acute cannabinoid CB1 receptor activation

Francisco M. Mouro, Vânia L. Batalha, Diana G. Ferreira et al. · Neuropharmacology · 2017 · 45 citations

Life Sciences, Neuroscience, Pharmacology +16

Chronic, intermittent treatment with a cannabinoid receptor agonist impairs recognition memory and brain network functional connectivity

Francisco M. Mouro, Joaquim A. Ribeiro, Ana M. Sebastião et al. · Journal of Neurochemistry · 2018 · 41 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Adenosine A_2Areceptors facilitate synaptic NMDA currents in CA1 pyramidal neurons

Francisco M. Mouro, Diogo M. Rombo, Raquel B. Dias et al. · British Journal of Pharmacology · 2018 · 37 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Memory deficits induced by chronic cannabinoid exposure are prevented by adenosine A2AR receptor antagonism

Francisco M. Mouro, Attila Köfalvi, L. André et al. · Neuropharmacology · 2019 · 33 citations · Full text

Medicine, Neuroscience, Pharmacology +10